Cash Flow from Operating Activities: A company's cash flows from operations.
Novo Nordisk A/S (NVO) had Cash Flow from Operating Activities of $18.03B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$12.34B |
|
$4.25B |
|
$2.32B |
|
$10.02B |
|
$7.29B |
|
$5.06B |
|
$342.88M |
|
$5.40B |
|
$5.40B |
|
$4.25B |
|
$4.25B |
|
$4.25B |
|
$4.25B |
|
$5.06B |
|
$5.81B |
|
4.44B |
|
4.45B |
|
$0.95 |
|
$0.95 |
|
| Balance Sheet Financials | |
$26.11B |
|
$31.55B |
|
$56.09B |
|
$82.20B |
|
$32.65B |
|
$18.01B |
|
$20.17B |
|
$52.82B |
|
$29.38B |
|
$9.69B |
|
$29.38B |
|
4.46B |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$18.03B |
$-11.98B |
|
$-4.30B |
|
$2.37B |
|
$4.01B |
|
$1.64B |
|
$217.26M |
|
$-7.84B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.80 |
|
-- |
|
-- |
|
0.38 |
|
0.67 |
|
81.17% |
|
40.98% |
|
40.98% |
|
-- |
|
43.76% |
|
34.41% |
|
$8.93B |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.31 |
|
0.91 |
|
98.46 |
|
14.46% |
|
43.84% |
|
5.17% |
|
8.96% |
|
$6.58 |
|
$2.01 |
|
$4.05 |
|